Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

MINNEAPOLIS – Believe it or not, the Minnesota Vikings had concerns about the Green Bay Packers getting to quarterback Sam Darnold. Yes, the same Sam Darnold who completed 33 of 43 passes for 377 ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...

There's just one task left for the Detroit Lions to clinch the No. 1 seed in the NFC. After the Minnesota Vikings beat the Green Bay Packers on Sunday, 27-25, in Week 17 of the NFL season, the ...

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $32.87, denoting a +0.67% change from the preceding trading day.

Viking Therapeutics Inc.’s stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company’s promising ...